Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...
The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the ...
The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.
TEVAN.UL] failed to convince a U.S. appeals court on Friday to reverse a decision that would remove patents related to its ...
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...
A new rule from the Food and Drug Administration (FDA) will update what it means for food to be labeled “healthy” for the ...
The U.S. Food and Drug Administration said on Thursday there was no longer a shortage of Eli Lilly’s (LLY.N) blockbuster ...
Under the previous FDA rule, which is being updated for the first time in 30 years, foods like salmon couldn't be labeled ...
The Food and Drug Administration (FDA) announced in a statement Tuesday that it has sent warning letters to companies selling ...
The U.S. Food and Drug Administration has declined to approve Zealand Pharma's bowel disease drug and sought an additional ...
Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...
Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and ...